Onfi (clobazam) Lawsuit in Pueblo, Colorado
Onfi (clobazam), an anti-seizure drug, has been linked to Stevens-Johnsons Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). According to an FDA warning issued on December 3, 2013, Onfi can cause these rare but serious skin reactions that can result in permanent harm and death. Lawsuits have been filed alleging that Pfizer failed to warn the public of the risk of Stevens Johnson syndrome associated with this drug. Speak to a CHICAGO Onfi lawyer if you believe you suffer from the side effects from Onfi.
Onfi skin reactions are extremely dangerous, painful, and disfiguring and can lead not only to life-threatening infections, but also organ damage, blindness, and death. The Pueblo, Colorado and Nationwide Onfi lawyers at TorHoerman Law are currently speaking to individuals prescribed Onfi who are experiencing symptoms of these rare skin diseases such as:
- Pain of the Skin
- Red or Purple Rashes that Spread from the Face
- Swelling of the Face or Tongue
- Skins Detaching or Sloughing Off in Sheets
- Blisters on the Mouth, Nose, or Eyes
- Fever, Chills, Headaches, Muscle Aches, Joint Pains
- Sore Throat
If you or a loved one is experiencing these symptoms, you may want to consider participation in the Pueblo, Colorado Onfi lawsuit. You should see your doctor to protect your health, but you may also want to consider speaking to a lawyer to protect your legal rights.
TorHoerman Law has a team of Onfi lawyers representing clients in Pueblo, Colorado who are here to help determine your rights and assist you in determining whether you should pursue compensation for your rare but serious skin disease in a Pueblo, Colorado Onfi litigation.
What is Onfi Prescribed for?
Onfi (clobazam) is an anti-seizure drug in category of drugs called benzodiazepines. Onfi is often prescribed in combination with other medications in an attempt to prevent seizures associated with a severe form of epilepsy called Lennox-Gaus.
The FDA Drug Safety Communication came after a review of adverse events linked the anti-seizure drug, Onfi, to 20 skin reactions involving Stevens-Johnsons Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The FDA is advising clinicians in Pueblo, Colorado to closely monitor patients taking Onfi for SJS and TEN, especially at the start of therapy or when the drug is reintroduced.
If you believe that you or a loved one may be one of the patients experiencing these painful skin reactions from your Onfi usage, you may want to consider protecting your legal rights by filing a Pueblo, Colorado Onfi lawsuit.
FDA Issues an FDA Warning – Onfi Causes Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Stevens-Johnsons Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but severe, life-threatening skin reactions that cause the top layer of skin to detach and fall off in large sheets. Sloughing skin may appear burned, while blisters may also develop on mucous membranes located at the eyes, mouth, and genitals and ultimately spread from all over the body to inside the intestines, lungs, and stomach. Onfi lawsuits in Pueblo, Colorado and nationwide allege that Pfizer should have warned the public of these life-threatening allergic reactions to their medication.
What should you do if you or a loved one are taking Onfi?
According to the FDA, if you are a patient currently taking Onfi, you should seek immediate medical treatment if you develop a rash, blistering or peeling of the skin, sores in the mouth or hives. Patients should not stop taking Onfi without first talking to their health care professional. Stopping Onfi suddenly can cause serious withdrawal problems, such as seizures that will not stop, hallucinations, shaking, nervousness and stomach or muscle cramps. Speak to your Pueblo, Colorado doctor or medical professional immediately.
Should I Participate in the Pueblo, Colorado Onfi SJS/TEN Lawsuit?
Pueblo, Colorado Onfi lawyers are discussing participation in the Pueblo, Colorado Onfi Lawsuit with individuals that suffered serious skin reactions as a result of their Onfi usage. Pueblo, Colorado Onfi lawsuits seek to compensate individuals seriously injured by Onfi.
If you or a loved one experienced symptoms of Steven-Johnson Syndrome or Toxic Epidermal Necrolysis and believes Onfi could be the cause, discussing your legal rights with a Pueblo, Colorado Onfi lawyer such as TorHoerman Law is recommended.
The Pueblo, Colorado Onfi lawyers at TorHoerman Law will not charge you for an initial consultation to discuss your Onfi Side Effects. You are not under any obligation to move forward with a Pueblo, Colorado Onfi lawsuit, until you determine this is the right option for yourself and your family. All information provided to the Pueblo, Colorado Onfi lawyers will be used to determine your legal rights to participate in the Pueblo, Colorado Onfi Side Effect Lawsuit and will be kept confidential.
Despite Questions over Safety, Onfi Sales Continue to Exceed Expectations
Onfi was approved on October 21, 2011 to treat sever seizures such as those that come from Lennox-Gastaut Syndrome.
Lennox-Gastaut syndrome usually begins before 4 years of age, and can be caused by a number of conditions, including brain malformations, severe head injuries, central nervous system infections, and inherited degenerative or metabolic conditions. In 30 to 35 percent of patients, no cause can be found. Patients commonly have frequent seizures of a wide variety, including tonic (stiffening of the body, upward deviation of the eyes, dilation of the pupils, and altered respiratory patterns), atonic (brief loss of muscle tone and consciousness, causing abrupt falls), atypical absence (staring spells), and myoclonic (sudden muscle jerks).
It is believed that less than 200,000 people in the U.S. have been diagnosed with Lennox-Gastaut syndrome. Lennox-Gastaut syndrome accounts for about 4 percent of all cases of childhood epilepsy and is more common in males than in females.
Onfi is manufactured by Lundbeck, a Danish Pharmaceutical company with U.S. offices in Deerfield Illinois. Despite the fact that there are not that many patients prescribed Onfi on a monthly basis, Lundbeck has seen an increase in profit of 122% from the third quarter of 2012 to the third quarter of 2013. Some of this profit is likely due to the fact that prices for each 30-day supply of Onfi sells for between $110 and $900.
Contact us by phone at 1-888-50-TORLAW or via email through the Contact Page.